↓ Skip to main content

PLOS

Comparative Performance of Electrochemiluminescence Immunoassay and EIA for HIV Screening in a Multiethnic Region of China

Overview of attention for article published in PLOS ONE, October 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
28 Mendeley
Title
Comparative Performance of Electrochemiluminescence Immunoassay and EIA for HIV Screening in a Multiethnic Region of China
Published in
PLOS ONE, October 2012
DOI 10.1371/journal.pone.0048162
Pubmed ID
Authors

Xiaohui Bi, Hongxia Ning, Tingting Wang, Dongdong Li, Yongming Liu, Tingfu Yang, Jiansheng Yu, Chuanmin Tao

Abstract

The recent approval of 4th generation HIV tests has forced many laboratories to decide whether to shift from 3rd to these tests. There are limited published studies on the comparative evaluation of these two different assays. We compare the performance of fourth-generation electrochemiluminescence immunoassay (ChIA) and third-generation enzyme linked immunosorbent assay (EIA) for human immunodeficiency virus (HIV) screening and gauge whether the shift from EIA to ChIA could be better in a multiethnic region of China.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 4%
Brazil 1 4%
Unknown 26 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 29%
Other 3 11%
Student > Master 3 11%
Student > Doctoral Student 2 7%
Student > Ph. D. Student 2 7%
Other 4 14%
Unknown 6 21%
Readers by discipline Count As %
Medicine and Dentistry 7 25%
Agricultural and Biological Sciences 5 18%
Neuroscience 2 7%
Social Sciences 2 7%
Nursing and Health Professions 1 4%
Other 5 18%
Unknown 6 21%